High adherence to HIV prophylaxis reduces chances of infection from partner, research findsBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f5470 (Published 11 September 2013) Cite this as: BMJ 2013;347:f5470
- Zosia Kmietowicz
Taking more action to ensure people take their tablets may be the key to improving the success of pre-exposure prophylaxis (PrEP), researchers have said.
In a trial in Uganda, the researchers found that a high level of adherence to PrEP gave 100% protection against HIV infection over an average of 11 months to heterosexuals who had an HIV positive partner.1
Several previous randomised controlled trials in various populations have reported levels of protection against HIV infection from PrEP of between 0% and 75%. One possible …